1. Home
  2. UPBD vs ATTO Comparison

UPBD vs ATTO Comparison

Compare UPBD & ATTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Upbound Group Inc.

UPBD

Upbound Group Inc.

N/A

Current Price

$15.81

Market Cap

1.1B

ML Signal

N/A

Logo Attovia Therapeutics Inc. Common Stock

ATTO

Attovia Therapeutics Inc. Common Stock

N/A

Current Price

$17.69

Market Cap

1.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
UPBD
ATTO
Founded
1986
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Diversified Commercial Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.0B
IPO Year
1996
2026

Fundamental Metrics

Financial Performance
Metric
UPBD
ATTO
Price
$15.81
$17.69
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
★ $32.25
N/A
AVG Volume (30 Days)
★ 784.7K
264.4K
Earning Date
04-30-2026
N/A
Dividend Yield
★ 8.25%
N/A
EPS Growth
N/A
★ N/A
EPS
★ 0.98
N/A
Revenue
★ $4,695,061,000.00
N/A
Revenue This Year
$5.96
N/A
Revenue Next Year
$6.47
N/A
P/E Ratio
$16.11
★ N/A
Revenue Growth
★ 8.67
N/A
52 Week Low
$15.37
$16.15
52 Week High
$23.98
$28.00

Technical Indicators

Market Signals
Indicator
UPBD
ATTO
Relative Strength Index (RSI) 25.65 34.80
Support Level N/A $16.15
Resistance Level $19.67 $24.89
Average True Range (ATR) 0.49 2.07
MACD -0.15 -0.70
Stochastic Oscillator 14.33 9.50

Price Performance

Historical Comparison
UPBD
ATTO

About UPBD Upbound Group Inc.

Upbound Group Inc is an omnichannel platform company committed to elevating financial opportunity for all through inclusive, and technology-driven financial solutions that address the evolving needs and aspirations of consumers. It has four operating segments; The Rent-A-Center Business segment operates lease-to-own stores, the Acima segment offers the lease-to-own transaction to consumers who do not qualify for financing from the traditional retailer, and also offers the lease-to-own transaction through virtual offering solutions, Mexico segment offers lease-to-own stores in Mexico. The The Brigit segment offers various financial health products and tools to help users improve their financial health. The company derives a majority of its revenue from the Acima segment.

About ATTO Attovia Therapeutics Inc. Common Stock

Attovia Therapeutics Inc is a clinical stage biotechnology company focused on research and development of therapeutic products in the fields of immune-mediated diseases. Its product pipeline includes ATTO-1310 and ATTO-2306 for immune-dermatology indications and ATTO-1091 for inflammatory diseases, including inflammatory bowel disease (IBD). The company's product candidates are developed using its ATTOBODY biologics platform.

Share on Social Networks: